SCHEMBL6153748

SCHEMBL6153748

FC(F)(F)c1cccc(Oc2cccc(-c3nnc(Nc4ccc(Cl)c(Cl)c4)s3)c2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GUSB P08236 2/20 0.54
P2RY1 P47900 1/20 0.46
EGFR P00533 6/20 0.45
ERBB2 P04626 6/20 0.45
BLM P54132 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 2/20 0.43
ERBB3 P21860 2/20 0.42
ERBB4 Q15303 2/20 0.42
POLB P06746 1/20 0.42
CTDSP1 Q9GZU7 1/20 0.42
ALDH1A1 P00352 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TLR8 Q9NR97 1/20 0.41
TLR7 Q9NYK1 1/20 0.41
PIK3CD O00329 1/20 0.40
PIK3CA P42336 1/20 0.40
PIK3CB P42338 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6153845 0.90 GUSB (0.48) GUSBP2RY1EGFRERBB2BLM
SCHEMBL6154359 0.88 GUSB (0.65) GUSBBLMMEN1KMT2AMAPT
SCHEMBL6155142 0.87 GUSB (0.60) GUSBBLMMEN1KMT2APOLB
SCHEMBL6154309 0.85 GUSB (0.58) GUSBBLMMEN1KMT2AMAPT
SCHEMBL6154575 0.83 GUSB (0.61) GUSBBLMMEN1KMT2APOLB
SCHEMBL6153840 0.83 GUSB (0.58) GUSBBLMMEN1KMT2APOLB
SCHEMBL6154135 0.83 GUSB (0.75) GUSBBLMMEN1KMT2AMAPT
SCHEMBL6155039 0.83 CLK4 (0.41) GUSBP2RY1NPSR1L3MBTL1PIM1
SCHEMBL6153833 0.82 GUSB (0.48) GUSBP2RY1BLMMEN1KMT2A
SCHEMBL6154200 0.81 GUSB (0.54) GUSBBLMMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US claimed
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP GUSB 2466/4885P2RY1 2072/4885EGFR 1109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.